SMG1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.031980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.500400E-01
Normal-vs-Stage2
1.129850E-01
Normal-vs-Stage3
1.903550E-01
Normal-vs-Stage4
9.760200E-01
Stage1-vs-Stage2
6.972200E-01
Stage1-vs-Stage3
8.752200E-02
Stage1-vs-Stage4
4.484200E-01
Stage2-vs-Stage3
3.792500E-02
Stage2-vs-Stage4
8.382000E-02
Stage3-vs-Stage4
1.165200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.037040E-01
Normal-vs-AfricanAmerican
4.824400E-01
Normal-vs-Asian
1.188040E-01
Caucasian-vs-AfricanAmerican
5.080400E-01
Caucasian-vs-Asian
4.511000E-01
AfricanAmerican-vs-Asian
3.338600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.110790E-01
Normal-vs-Female
1.157180E-01
Male-vs-Female
7.743600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.540600E-01
Normal-vs-Age(41-60Yrs)
2.772600E-01
Normal-vs-Age(61-80Yrs)
6.625600E-02
Normal-vs-Age(81-100Yrs)
1.278010E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.923800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.331800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.695400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.347900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.131980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.984800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.360000E-02
Normal-vs-Daily Drinker
8.404200E-02
Normal-vs-Weekly Drinker
1.254000E-01
Normal-vs-Occasional Drinker
1.487360E-01
Normal-vs-Social Drinker
1.709360E-01
Non Drinker-vs-Daily Drinker
5.988200E-01
Non Drinker-vs-Weekly Drinker
8.276400E-01
Non Drinker-vs-Occasional Drinker
6.216600E-01
Non Drinker-vs-Social Drinker
4.131800E-01
Daily Drinker-vs-Weekly Drinker
8.242800E-01
Daily Drinker-vs-Occasional Drinker
3.672400E-01
Daily Drinker-vs-Social Drinker
2.381800E-01
Weekly Drinker-vs-Occasional Drinker
5.471400E-01
Weekly Drinker-vs-Social Drinker
3.741000E-01
Occasional Drinker-vs-Social Drinker
7.498600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.140620E-01
Normal-vs-Grade 2
9.855600E-03
Normal-vs-Grade 3
7.656000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.643800E-02
Grade 1-vs-Grade 3
1.712250E-02
Grade 1-vs-Grade 4
1.140620E-01
Grade 2-vs-Grade 3
1.731170E-01
Grade 2-vs-Grade 4
9.855600E-03
Grade 3-vs-Grade 4
7.656000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.356100E-02
Normal-vs-NonDiabetic
4.786100E-02
Diabetic-vs-NonDiabetic
6.973800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.243200E-01
Normal-vs-NoPancreatitis
5.348500E-02
Pancreatitis-vs-NoPancreatitis
7.508800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.288760E-01
Normal-vs-N1
1.143810E-01
N0-vs-N1
4.276600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.714000E-01
Normal-vs-TP53-NonMutant
2.013000E-01
TP53-Mutant-vs-TP53-NonMutant
1.570560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
